P2.14-05 A Phase II Study of Sintilimab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer:SINCE-01 Trial
- 作者单位
- 2Shandong First Medical University and Shandong Academy of Medical Science, Jinan/CN 1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan/CN
- 刊名
- Journal of Thoracic Oncology
- 年份
- 2023
- 卷号
- Vol.18 No.11Suppl
- 页码
- S372-S373
- ISSN
- 1556-0864
- 摘要
- Moulin MA, Albessard F, Lacotte J, Camsonne R.
- 文献类型
- 期刊
- 浏览量
- 1
-
被引次数
-
收录
CPCI-S
Scopus
相同作者文献
- [1] L. Li;J. Zheng;Z. Liu;Y. Huang;J. Xiao;S. Wang;Q. Yu;Q. Zhang;X. Hu;W. Zhao;W. Hou;F.-M. Kong;J. Yu;S. Yuan . Pre-treatment F-RGD Uptake may Predict Adverse Events during Apatinib Antiangiogenic Therapy[J] Clinical Oncology 2022 . Vol.34 No.6 . e238-e245 .
- [2] L Li, J Zheng, Z Liu, Y Huang, J Xiao, S Wang, Q Yu, Q Zhang, X Hu, W Zhao, W Hou, F-M Spring Kong, J Yu, S Yuan . Pre-treatment F-RGD Uptake may Predict Adverse Events during Apatinib Antiangiogenic Therapy[J] Clinical oncology (Royal College of Radiologists (Great Britain)) 2022 .